Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Alzheimer's Disease
and you are
over 55
years old
The phase for this study is not defined.
Show me locations

The purpose

The main objective of this study is to investigate the effects of repetitive Transcranial Magnetic Stimulation (rTMS) treatment on patients with probable early or moderate Alzheimer's disease.

Provided treatments

  • Device: rTMS active treatment
  • Device: rTMS sham treatment
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02908815. The sponsor of the trial is University of Manitoba and it is looking for 200 volunteers for the current phase.
Official trial title:
Investigating the Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) as a Treatment for Alzheimer's Disease